Professor Anthony Gill
Anthony is Professor of Surgical Pathology at the University of Sydney and current chairman of the Australian Pancreatic Genome Initiative (APGI). He graduated in medicine from the University of Sydney in 1997. He completed his specialty training in surgical pathology (FRCPA) in 2005 and since then has divided his time between diagnostic pathology as a senior staff specialist at Royal North Shore Hospital and medical research. His research has concentrated on translating advances made in the understanding of cancer at the basic science or molecular level into diagnostic tests which can be applied in the routine surgical pathology laboratory on patient biopsy specimens. He was awarded the prestigious Benjamin Castleman award in 2011 and the Ramzi Cotran you Investigator Award in 2017 by the United States and Canadian Academy of Pathology (USCAP) as well as the John Loewenthal Medal and a higher doctorate by publication (MD) from the University of Sydney in 2011; the NSW Premier’s Award for Excellence in Translational Cancer Research in 2013 and the Sir Zelman Cowen Universities Prize for discovery in Medical Research in 2014. In addition to chairing the APGI, he leads the Cancer Diagnosis and Pathology Research Group (http://www.cancerdxpathology.org.au/) which concentrates on research in other areas of surgical pathology. He has authored more than 250 peer reviewed publications and was a member of the WHO consensus committee which recently finalized the newly released WHO 2017 classification of endocrine neoplasia.